InsiderClue
Stocks · Health care · Services-Medical Laboratories

CareDx, Inc.

CDNA Clue Score46
United States Fiscal year ends December CIK 0001217234
$63.67 +2.36% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $63.67 −0.31% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back. P/E and P/FCF are the market value over the last full fiscal year's net income or free cash flow, as public on each day, so they step once a year when the annual report comes out. A hatched band marks a stretch with none: a year of net loss, or of cash burnt.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2016Revenue40.6Operating income−37.3Net income−39.5EPS, diluted−2.39Fiscal year 2017Revenue48.3 +18.9%Operating income−20.3Net income−55.5EPS, diluted−2.38Fiscal year 2018Revenue76.6 +58.4%Operating income−15.6Net income−46.8EPS, diluted−1.31Fiscal year 2019Revenue127.1 +66.0%Operating income−24.5Net income−22.0EPS, diluted−0.52Fiscal year 2020Revenue192.2 +51.3%Operating income−22.5Net income−18.7EPS, diluted−0.40Fiscal year 2021Revenue296.4 +54.2%Operating income−29.7Net income−30.7EPS, diluted−0.59Fiscal year 2022Revenue321.8 +8.6%Operating income−77.2Net income−76.6EPS, diluted−1.44Fiscal year 2023Revenue280.3 −12.9%Operating income−203.4Net income−190.3EPS, diluted−3.54Fiscal year 2024Revenue333.8 +19.1%Operating income40.8Net income52.5EPS, diluted0.93Fiscal year 2025Revenue379.8 +13.8%Operating income−30.8Net income−21.4 −140.6%EPS, diluted−0.40
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue 40.6 48.3 76.6 127.1 192.2 296.4 321.8 280.3 333.8 379.8
Growth +18.9% +58.4% +66.0% +51.3% +54.2% +8.6% −12.9% +19.1% +13.8%
Operating income −37.3 −20.3 −15.6 −24.5 −22.5 −29.7 −77.2 −203.4 40.8 −30.8
Net income −39.5 −55.5 −46.8 −22.0 −18.7 −30.7 −76.6 −190.3 52.5 −21.4
Growth −140.6%
EPS, diluted −2.39 −2.38 −1.31 −0.52 −0.40 −0.59 −1.44 −3.54 0.93 −0.40

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Gross marginOperating marginNet margin
Fiscal year 2016Operating margin−91.9%Net margin−97.1%Free cash flow margin−42.0%Fiscal year 2017Gross margin55.8%Operating margin−42.0%Net margin−114.8%Free cash flow margin−30.0%Fiscal year 2018Gross margin56.9%Operating margin−20.3%Net margin−61.1%Free cash flow margin−7.9%Fiscal year 2019Gross margin64.2%Operating margin−19.3%Net margin−17.3%Fiscal year 2020Operating margin−11.7%Net margin−9.7%Fiscal year 2021Operating margin−10.0%Net margin−10.3%Fiscal year 2022Operating margin−24.0%Net margin−23.8%Fiscal year 2023Operating margin−72.5%Net margin−67.9%Fiscal year 2024Operating margin12.2%Net margin15.7%Fiscal year 2025Operating margin−8.1%Net margin−5.6%
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Gross margin n/a 55.8% 56.9% 64.2% n/a n/a n/a n/a n/a n/a
Operating margin −91.9% −42.0% −20.3% −19.3% −11.7% −10.0% −24.0% −72.5% 12.2% −8.1%
Net margin −97.1% −114.8% −61.1% −17.3% −9.7% −10.3% −23.8% −67.9% 15.7% −5.6%
Free cash flow margin −42.0% −30.0% −7.9% n/a n/a n/a n/a n/a n/a n/a

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2016Operating cash flow−16.5Capital expenditure−0.5Free cash flow−17.1Fiscal year 2017Operating cash flow−14.3Capital expenditure−0.2Free cash flow−14.5Fiscal year 2018Operating cash flow−4.0Capital expenditure−2.0Free cash flow−6.0Fiscal year 2019Operating cash flow−2.8Fiscal year 2020Operating cash flow33.4Buybacks0.0Fiscal year 2021Operating cash flow−19.3Buybacks0.0Fiscal year 2022Operating cash flow−25.2Buybacks−0.6Fiscal year 2023Operating cash flow−18.4Buybacks−27.5Fiscal year 2024Operating cash flow38.0Buybacks−0.5Fiscal year 2025Operating cash flow42.0Buybacks−87.8
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −16.5 −14.3 −4.0 −2.8 33.4 −19.3 −25.2 −18.4 38.0 42.0
Capital expenditure −0.5 −0.2 −2.0 n/a n/a n/a n/a n/a n/a n/a
Free cash flow −17.1 −14.5 −6.0 n/a n/a n/a n/a n/a n/a n/a
Growth
Buybacks n/a n/a n/a n/a 0.0 0.0 −0.6 −27.5 −0.5 −87.8

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2016Cash17.3Total debt23.9Net cash (debt)−6.7Shareholders’ equity19.5Debt to equity1.23Fiscal year 2017Cash16.9Total debt34.1Net cash (debt)−17.2Shareholders’ equity−6.1Fiscal year 2018Cash64.6Total debt0.0Net cash (debt)64.6Shareholders’ equity95.9Debt to equity0.00Fiscal year 2019Cash38.2Total debt0.0Net cash (debt)38.2Shareholders’ equity99.0Debt to equity0.00Fiscal year 2020Cash134.7Total debt0.0Net cash (debt)134.7Shareholders’ equity277.7Debt to equity0.00Fiscal year 2021Cash348.5Shareholders’ equity465.9Fiscal year 2022Cash89.9Shareholders’ equity430.9Fiscal year 2023Cash82.2Shareholders’ equity261.3Fiscal year 2024Cash114.7Shareholders’ equity378.4Fiscal year 2025Cash65.4Shareholders’ equity303.1
FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 17.3 16.9 64.6 38.2 134.7 348.5 89.9 82.2 114.7 65.4
Total debt 23.9 34.1 0.0 0.0 0.0 n/a n/a n/a n/a n/a
Net cash (debt) −6.7 −17.2 64.6 38.2 134.7 n/a n/a n/a n/a n/a
Shareholders’ equity 19.5 −6.1 95.9 99.0 277.7 465.9 430.9 261.3 378.4 303.1
Debt to equity 1.23 n/a 0.00 0.00 0.00 n/a n/a n/a n/a n/a

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2016 31 Dec 2016 FY2017 31 Dec 2017 FY2018† 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Operations
−16.5 −14.3 −4.0 −2.8 33.4 −19.3 −25.2 −18.4 38.0 42.0
Growth −157.7% +10.5%
2.9 n/a n/a n/a n/a 8.8 11.6 14.4 14.2 15.0
Investment
−0.5 −0.2 −2.0 n/a n/a n/a n/a n/a n/a n/a
calc −17.1 −14.5 −6.0 n/a n/a n/a n/a n/a n/a n/a
Growth
calc −1.03 −0.62 −0.17 n/a n/a n/a n/a n/a n/a n/a
−21.1 −6.1 −7.9 −22.6 −100.4 47.7 −228.5 40.4 −0.5 2.2
Financing
24.9 29.4 50.3 −0.1 163.1 185.6 −4.5 −29.6 −5.6 −93.4
n/a n/a n/a n/a 0.0 0.0 −0.6 −27.5 −0.5 −87.8

† The diluted share count jumps at 2018, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative.